News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
181–216
Matches
590
Sources here
21
Companies here
9
Search results Stored financial headlines

Active search

590 matching headlines

Ticker or company: MGMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

MGE Energy says about $3.9M in gains aided its Q2 earnings

MGE Energy (Nasdaq: MGEE) reported Q2 2026 GAAP earnings of $33.4 million, or $0.89 per share, an increase from $26.5 million, or $0.72 per share, in the prior year. The earnings growth was supported by a $3.0 million increase in the electric segment due …

MGEE main company
Sharemaestro market context Trend signal active 52 weeks -4.6% · Next-week setup negative 42.9% MGEE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Flash (MGEE) MGE Energy, Inc. Reports Q2 Revenue $161.2M

MGE Energy, Inc. (MGEE) reported its Q2 revenue at $161.2 million. This announcement is part of a series of recent financial updates, including Q2 EPS of $0.89 against an estimated $0.77, and a consistent quarterly dividend of $0.475 per share. The company's stock experienced …

MGEE main company
Sharemaestro market context Trend signal active 52 weeks -4.6% · Next-week setup negative 42.9% MGEE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amgen stock hits all-time high at 398.65 USD

Amgen Inc. stock has reached an all-time high of $398.65, currently trading at $403.13, giving the biotechnology giant a market capitalization of $210.5 billion. The surge reflects investor confidence following strong performance, with the stock price increasing by 37.01% over the past year and …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amgen (AMGN) Could Be 8% Overvalued Following Raised 2026 Guidance

Amgen (AMGN) reported strong Q2 2026 results, beating analyst expectations and raising its full-year revenue and earnings guidance. Despite a significant share price increase, Simply Wall St's narrative valuation suggests the stock is 8.3% overvalued at $390.02, with a fair value of $359.98, while …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amgen gains after strong quarterly results and continued product momentum

Amgen's shares rose approximately 4% after the biotechnology company announced second-quarter 2026 results that exceeded Wall Street expectations. The company reported adjusted earnings per share of $6.29 and revenue of $10.05 billion, driven by a 10% year-over-year increase in total revenue and double-digit sales …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

A Quant Signal Flashes Enticingly for MGM Resorts (MGM) Stock Call Options

MGM Resorts International hotel by- atosan via iStock At first glance, it's natural to be apprehensive about MGM Resorts (MGM). Sure, MGM stock itself is ranked as a 40% Buy, according to the Barchart Technical Opinion indicator. Further, the technical profile suggests a continuation …

MGM main company MGM main company
Sharemaestro market context Trend signal active 52 weeks +6.7% · Next-week setup negative 38.9% MGM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Board Change and Q2 Results Could Be A Game Changer For Mettler-Toledo International (MTD)

Mettler-Toledo International Inc. recently reported second-quarter 2026 results showing higher sales of US$1,027.31 million and net income of US$232.90 million, while also appointing MISTRAS Group CEO Natalia Shuman to its Board of Directors effective 3 August 2026. Together with Baron Capital's decision to increase …

MG main company
Sharemaestro market context Trend signal started 52 weeks +88.3% MG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What Are Wall Street Analysts' Target Price for MGM Resorts Stock?

MGM Resorts International hotel by- atosan via iStock MGM Resorts International (MGM), headquartered in Las Vegas, Nevada, owns and operates casino, hotel, and entertainment resorts. Valued at $11.2 billion by market cap, the company offers accommodation, dining, meeting, convention, and hospitality management services for …

MGM main company MGM main company
Sharemaestro market context Trend signal active 52 weeks +6.7% · Next-week setup negative 38.9% MGM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Liberty Metals Appoints Former IAMGOLD President & CEO Steve Letwin as Non-Executive Director

Liberty Metals Limited (ASX:LIB) has appointed Steve Letwin, former President and CEO of IAMGOLD Corporation, as a Non-Executive Director, effective August 5, 2026. Mr. Letwin brings over four decades of experience in the global resources and energy sectors, including corporate finance, operational management, and …

IAG main company
Sharemaestro market context Price above Trend Line 52 weeks +108.7% IAG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MGM Resorts International $MGM Holdings Increased by California State Teachers Retirement System

California State Teachers Retirement System has increased its stake in MGM Resorts International (NYSE:MGM) by 23.2% in the first quarter, now owning 236,707 shares valued at $8.76 million. Other institutional investors have also adjusted their holdings, contributing to 68.11% institutional ownership. Analysts maintain a …

MGM main company
Sharemaestro market context Trend signal active 52 weeks +15.9% · Next-week setup negative 44.5% MGM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MGM Legal News: MGM Resorts Hit with Investigation over

Bleichmar Fonti & Auld LLP is investigating Barry Diller's $48.30 per share offer to acquire MGM Resorts International due to potential breaches of fiduciary duty and conflicts of interest. Diller, an MGM director and founder of People, Inc. (MGM's largest stockholder), "stands on both …

MGM main company
Sharemaestro market context Trend signal active 52 weeks +15.9% · Next-week setup negative 44.5% MGM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Amgen reported strong second-quarter 2026 financial results, with total revenues increasing 10% to $10.1 billion and product sales growing 9%, driven by volume. The company saw significant growth in several key products like Repatha, EVENITY, and TEPEZZA, and provided updates on its extensive pipeline, …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Did MGIC’s EPS Beat Amid Margin Pressure Just Shift MGIC Investment's (MTG) Investment Narrative?

MGIC Investment Corporation recently reported its second-quarter 2026 results, with revenue of US$295.39 million and net income of US$182.15 million, while also confirming a quarterly dividend of US$0.17 per share payable on August 20, 2026. Despite modest year-on-year declines in revenue and net income, …

MTG main company
Sharemaestro market context Trend signal active 52 weeks +12.6% · Next-week setup positive 59.7% MTG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AMGEN INC : JEFFERIES RAISES TARGET PRICE TO $385 FROM $346

Jefferies has increased its target price for Amgen Inc. (AMGN) to $385 from $346. This information, provided by Reuters, indicates an analyst's revised valuation for the pharmaceutical company. The article also includes a disclaimer stating that the content reflects only the author's opinion and …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arrowstreet Capital Limited Partnership Takes $2.73 Million Position in MGP Ingredients, Inc. $MGPI

Arrowstreet Capital Limited Partnership has acquired a new position in MGP Ingredients, Inc. (MGPI), purchasing 148,160 shares valued at approximately $2.73 million, representing a 0.69% stake in the company. Other institutional investors have also adjusted their holdings. MGP Ingredients reported strong quarterly EPS of …

MGPI main company
Sharemaestro market context Price below Trend Line 52 weeks -40.2% · Next-week setup negative 40.3% MGPI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MGIC Investment Corp (MTG) President & COO Salvatore Miosi Sells 30,000 Shares

MGIC Investment Corp's President & COO, Salvatore Miosi, sold 30,000 shares of MTG stock for approximately $891,000, continuing a trend of insider selling. Over the past year, there have been 20 insider sells and zero insider buys, signaling that insiders may view the stock …

MTG main company
Sharemaestro market context Trend signal active 52 weeks +12.6% · Next-week setup positive 59.7% MTG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AMGEN INC : OPPENHEIMER RAISES TARGET PRICE TO $450 FROM $400

Oppenheimer has increased its target price for Amgen Inc. to $450 from $400. The article, sourced from Reuters, includes a disclaimer stating that its content reflects only the author's opinion and is not investment advice.

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AMGEN INC : TRUIST SECURITIES RAISES TARGET PRICE TO $362 FROM $340

Truist Securities has increased its target price for Amgen Inc. (AMGN) from $340 to $362. This update reflects the analyst firm's revised outlook on the biotechnology company's financial prospects. The information is presented by Reuters.

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AMGEN DATA BREACH: Edelson Lechtzin LLP Launches Class

Edelson Lechtzin LLP has launched a class action investigation into a data breach at Amgen Inc. The breach, identified in July 2026, involved unauthorized activity in cloud environments resulting in the exfiltration of patient protected health information and proprietary company data. The law firm …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cloudflare CEO Slams Vail Resorts' New Board Pick as Park City Standoff Drags On

Cloudflare CEO Matthew Prince has publicly criticized Vail Resorts' decision to appoint MGM Resorts International CEO Bill Hornbuckle to its board. Prince, a Park City billionaire, has been campaigning for over a year to purchase Park City Mountain Resort, accusing Vail of underinvesting in …

MGM main company
Sharemaestro market context Trend signal active 52 weeks +15.9% · Next-week setup negative 44.5% MGM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amgen raises 2026 EPS, revenue guidance as Q2 beats on both lines (AMGN:NASDAQ)

Amgen (AMGN) has raised its 2026 profit and revenue guidance after reporting strong Q2 financial results that exceeded expectations. The biopharma company now projects full-year non-GAAP EPS between $22.30 and $23.50, and revenue between $38 billion and $39.4 billion, both higher than previous estimates …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IAMGOLD Corp expected to post earnings of 52 cents a share - Earnings Preview

IAMGOLD Corp (TSX:IMG) is projected to report earnings of 52 cents per share, according to a Reuters earnings preview. The full article can be accessed by TradingView subscribers.

IAG main company
Sharemaestro market context Price above Trend Line 52 weeks +108.7% IAG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Highlights from Amgen's 2026 Second Quarter Earnings Report

Amgen released its 2026 second quarter earnings report, showcasing strong performance driven by key growth drivers that increased 26% year over year and accounted for nearly 70% of product sales. Chairman and CEO Robert A. Bradway expressed confidence in the company's ability to sustain …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amgen Inc Stock (AMGN) Closed Up by 3.03% on Aug 4: Key Drivers Unveiled

Amgen Inc (AMGN) stock rose by 3.03% due to strong second-quarter earnings that surpassed expectations, positive interim clinical trial data for a metabolic health candidate, and supportive broader market sentiment for defensive healthcare stocks. The company's robust core product portfolio growth, improved operating margins, …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment

Amgen has raised its full-year revenue outlook to between $38.2 billion and $39.4 billion due to strong drug sales in the second quarter. However, the biotechnology company also announced it would halt the development of AMG 513, an early-stage obesity treatment that was in …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MGIC Investment (NYSE: MTG) COO sells 30,000 shares under 10b5-1 trading plan

Salvatore A. Miosi, President & COO of MGIC Investment Corp (NYSE: MTG), sold 30,000 shares of common stock on August 3, 2026, at $29.70 per share. This sale was conducted under a Rule 10b5-1 trading plan adopted on March 2, 2026. Following the transaction, …

MTG main company
Sharemaestro market context Trend signal active 52 weeks +12.6% · Next-week setup positive 59.7% MTG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amgen second-quarter sales rise 9%, profit tops Street view

Amgen reported a 9% rise in second-quarter sales and adjusted earnings that surpassed analyst expectations, driven by strong demand for drugs like Repatha and Evenity. The company also raised its full-year revenue and profit outlook, despite discontinuing an experimental obesity drug candidate (AMG 513). …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Flash (AMGN) Amgen Inc. Reports Q2 Revenue $10.05B, vs. FactSet Est of $9.43B

Amgen Inc. reported its second-quarter revenue reached $10.05 billion, surpassing FactSet's estimate of $9.43 billion. This earnings flash indicates strong financial performance for the biotechnology group, exceeding analyst expectations for the quarter. The company also announced lifting its outlook on strong Q2 drug sales, …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amgen Inc. Cloud Data Breach Exposes Patient PHI in 2026 Cybersecurity Incident Analysis

In July 2026, Amgen Inc. disclosed a cybersecurity incident involving unauthorized access to its third-party-hosted cloud storage systems, resulting in the exfiltration of proprietary data and patient PHI. The company promptly initiated its incident response, engaged forensics experts, and notified the SEC. While the …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context